<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03579420</url>
  </required_header>
  <id_info>
    <org_study_id>bPEGT2</org_study_id>
    <nct_id>NCT03579420</nct_id>
  </id_info>
  <brief_title>Efficacy of a Brief Lifestyle Intervention in Type 2 Diabetes, Compared With a Longer Group Educational Program</brief_title>
  <official_title>Efficacy of a Brief Group Program Versus a Longer Structured Program for Therapeutic Education of Patients With Type 2 Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria Careggi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria Careggi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will compare two different programs for lifestyle intervention in type 2 diabetes:

        1. A brief group program, with three weekly sessions

        2. A longer group program, with six weekly sessions, which has been routinely used for the
           management of type 2 diabetic patients in this hospital for several years.

      The aim is that of demonstrating the non-inferiority of the new brief, and more sustainable,
      program, in comparison with the more traditional approach.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c at 6 months</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment success at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>HbA1c within predefined target without any increase in pharmacological therapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment success at 24 months</measure>
    <time_frame>24 months</time_frame>
    <description>HbA1c within predefined target without any increase in pharmacological therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c at 24 months</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MEditerranean DIet adherence LITErature-based (MEDI-LITE) questionnaire scores</measure>
    <time_frame>24 months</time_frame>
    <description>14-item questionnaire with scores ranging from 0 (low adherence) to 18 (high adherence)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Physical Activity Questionnaire-Short Form (IPAQ-SF) scores</measure>
    <time_frame>24 months</time_frame>
    <description>7-item questionnaire with scores ranging from 0 (no activity) to 7 (high activity)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Well-being Enquiry in Diabetics (WED) questionnaire total score</measure>
    <time_frame>24 months</time_frame>
    <description>50-item questionnaire measuring diabetes-specific health-related quality of life, with scores ranging from 0 (low) to 50 (high). Only total score will be used in analysis 1. Mannucci E, et al., Diabetes Nutr Metab 9: 89-102, 1996).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">226</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Brief lifestyle program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3-session lifestyle group intervention program focussed on physical activity and eating habits, using interactive methods and a behavioral approach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional lifestyle longer program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6-session lifestyle group intervention program focussed on physical activity and eating habits, using traditional lessons and interactive methods</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief lifestyle program</intervention_name>
    <description>3-session program for modification of lifestyle habits (exercise and diet)</description>
    <arm_group_label>Brief lifestyle program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Conventional lifestyle program</intervention_name>
    <description>6-session program for modification of lifestyle habits (exercise and diet)</description>
    <arm_group_label>Traditional lifestyle longer program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  HbA1c between 48 and 75 mmol/mol

        Exclusion Criteria:

          -  Axis I Mental Disorders

          -  Heart failure (NYHA Class III or IV)

          -  Foot ulcers or lower limb amputations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mattreo Monami, MD</last_name>
    <phone>3384027484</phone>
    <email>matteo.monami@unifi.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diabetologia AOU Careggi</name>
      <address>
        <city>Florence</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matteo Monami, MD</last_name>
      <phone>3384027484</phone>
      <email>matteo.monami@unifi.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 1, 2018</study_first_submitted>
  <study_first_submitted_qc>June 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2018</study_first_posted>
  <last_update_submitted>June 25, 2018</last_update_submitted>
  <last_update_submitted_qc>June 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero-Universitaria Careggi</investigator_affiliation>
    <investigator_full_name>Edoardo Mannucci</investigator_full_name>
    <investigator_title>Director, Diabetology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

